Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Otter Pharmaceuticals
Lake Forest, Illinois, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Otter Pharmaceuticals, a subsidiary of Assertio Holdings, markets approved pharmaceutical products, most notably clobazam (targeting the GABAA receptor) for Lennox-Gastaut syndrome and methotrexate (targeting DHFR) for autoimmune indications such as psoriasis. Clobazam is commercialized as Sympazan® oral film for adjunctive treatment of seizures in LGS; methotrexate is provided via the OTREXUP device for subcutaneous delivery in conditions including psoriasis. Both products are approved and sold in multiple markets.
- Therapeutic areas
- NeurologyDermatology
- Modalities
- Small molecule
- Industry
- Biotech
02
Partnerships
Aquestive Therapeutics
Beyond the preview
Go deeper on Otter Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Otter Pharmaceuticals.